Sucampo Pharmaceuticals, Inc. (SCMP) Reports Q3 Loss of $0.10, Sales Miss Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Income (loss) from operations: 13.27M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income (loss) from operations: 13.27M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q3 EPS of ($0.10), versus $0.05 reported last year. Revenue for the quarter came in at $14.37 million, versus $20.9 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ralliant Corporation (RAL) Tops Q3 EPS by 22c ; Offers Guidance
- Acushnet (GOLF) Misses Q3 EPS by 15c; Offers Guidance
- Stanley Black & Decker (SWK) Tops Q3 EPS by 75c; lifts forecast
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
